Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Junshan Biotechnology is a Chinese biotechnology company specializing in the research, development, and industrialization of functional probiotics and live biotherapeutic products (LBPs). The company focuses on the gut-brain axis and metabolic health, leveraging a proprietary library of microbial strains to address conditions such as hyperuricemia, obesity, and diabetes. Junshan Bio operates a comprehensive platform covering strain screening, functional verification, and large-scale fermentation. Their product portfolio includes both clinical-grade microbial therapies and functional food ingredients aimed at improving human health through microbiome modulation. The company has established significant research collaborations with academic institutions to validate the efficacy of its proprietary strains and maintains a GMP-compliant manufacturing facility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 河南君善生物技术.